MRC1 and metabolic dysfunction-associated steatotic liver disease: MRC1, a surface marker of M2 or anti-inflammatory macrophages, was previously found increased in SAT from obese subjects with NAFLD versus obese with normal intrahepatic triglyceride content and lean control patients [57].